VKTX — Viking Therapeutics Share News
0.000.00%
Last trade - 00:00Structure Therapeutics surges after weight-loss drug succeeds mid-stage trial
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Viking Therapeutics Highlights Clinical Data From VK2735 Obesity Program In Presentation At ObesityWeek 2025
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Viking Therapeutics misses Q3 profit estimates
Brief: Viking Therapeutics Q3 EPS USD -0.81 Vs. IBES Estimate USD -0.7
U.S. STOCKS ON THE MOVE- SLB NV, Bank OZK, Gilead Sciences
Obesity drugmakers slip after Trump vows to lower weight-loss drug prices
U.S. STOCKS ON THE MOVE- Oklo, Boston Scientific, Agios
U.S. STOCKS ON THE MOVE-Oracle, American Express, Magna International
Obesity drugmakers slip after Trump vows to lower weight-loss drug prices
Factbox: Top pharma companies work to launch first weight-loss pill
Eli Lilly rises after pill cuts body weight by 10.5% in diabetes patients
Street View: Analysts expect Viking's obesity pill to remain competitive despite trial setback
U.S. STOCKS ON THE MOVE-Medtronic, NorthWestern Energy, GM
Viking Therapeutics plunges after oral obesity pill data misses expectations